Загрузка...
Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
OBJECTIVE: Metaplastic breast cancer (MetaBC) is a rare breast cancer subtype poorly responsive to systemic therapy in the metastatic setting with high recurrence rates in the adjuvant setting. However, limited data exist regarding response to neoadjuvant chemotherapy (NAC). We performed a single in...
Сохранить в:
| Опубликовано в: : | Breast Cancer Res Treat |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469521/ https://ncbi.nlm.nih.gov/pubmed/31119569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-019-05264-2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|